| Literature DB >> 31022980 |
Joaquín S Galindo Muñoz1, Juana María Morillas-Ruiz2, María Gómez Gallego3, Inmaculada Díaz Soler4, María Del Carmen Barberá Ortega5, Carlos M Martínez6, Juan José Hernández Morante7.
Abstract
Obesity has been associated with impaired cognitive performance. This study aimed to determine whether improvements in cognitive function may contribute to higher weight loss in patients with obesity. In this randomised, 12-week trial, participants with overweight/obesity were randomised into a cognitive training intervention (Cognitive) group or a cognitive-behavioural (Control) group. In addition, both groups followed a hypocaloric dietary treatment. Cognitive functioning measurements and anthropometrical parameters were evaluated. All cognitive measures improved in the intervention group (p < 0.005 in all contrasts). In controls, significant improvements in attention, flexibility and task planning were also observed. Regarding anthropometrical parameters, the effect of the intervention in the cognitive group was higher for the total percentage of weight loss, body mass index (BMI), body fat and waist circumference. Biochemical parameters improved in both groups. Attending to our data, cognitive training was more effective that the hypocaloric intervention alone, partly related to an improvement in the working memory. Despite the shortage of training interventions for executive functions in the context of weight control, this type of combined intervention could establish the first steps towards a more appropriate intervention for patients with obesity.Entities:
Keywords: clinical trial; cognitive training; decision-making; executive function; weight loss
Mesh:
Year: 2019 PMID: 31022980 PMCID: PMC6521325 DOI: 10.3390/nu11040925
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Flow diagram of the trial.
Baseline participant clinical, anthropometrical and cognitive characteristics.
| CONTROL | COGNITIVE | Sig. | |
|---|---|---|---|
| Age (years) | 46 ± 7 | 44 ± 10 | 0.376 |
| BMI (kg/m2) | 31.18 ± 3.98 | 31.71 ± 4.20 | 0.643 |
| Waist | 101.4 ± 10.0 | 101.9 ± 11.2 | 0.856 |
| Body fat (%) | 37.62 ± 7.99 | 37.04 ± 6.09 | 0.764 |
| SBP (mmHg) | 130 ± 13 | 118 ± 16 | 0.220 |
| DBP (mmHg) | 79 ± 7 | 71 ± 9 | 0.120 |
| FPG (mg/dl) | 101 ± 23 | 93 ± 10 | 0.089 |
| Triglycerides (mg/dl) | 117 ± 49 | 107 ± 27 | 0.144 |
| cHDL (mg/dl) | 34 ± 11 | 43 ± 11 | 0.015 |
| Cognitive variables | |||
| Working memory (Z-L-N score) | 0.80 ± 1.06 | 1.04 ± 1.02 | 0.433 |
| Selective attention (Z-Total d2 test) | 0.23 ± 1.52 | 0.04 ± 1.34 | 0.656 |
| Z-Focusing Index (d2 test) | −0.66 ± 1.53 | −0.70 ± 1.27 | 0.913 |
| Z-Inhibition (5-digit test) | 0.26 ± 1.10 | 0.17 ± 0.78 | 0.997 |
| Z-Flexibility (5-digit test) | −0.21 ± 1.36 | −0.42 ± 1.01 | 0.598 |
| Task planning (Z score 30 min) | 1.90 ± 0.69 | 1.96 ± 1.11 | 0.884 |
| Decision making (Z-IGT score) | −0.82 ± 1.49 | −0.31 ± 1.39 | 0.223 |
Data represent Mean ± SD. BMI = body mass index, SBP = Systolic blood pressure, DBP = diastolic blood pressure, FPG = fasting plasma glucose, TOT = total d2 test effectiveness, FI = Focusing index, Min = minutes. IGT = Iowa Gambling Task. Cognitive variables were standardized to z-scores.
Three-month change estimates for executive function variables by treatment.
| BASELINE | Observed Mean ± SD Change from Baseline | Mean between Group Difference (Control vs. Cognitive) 95% CI | Significance (ANCOVA) | |||
|---|---|---|---|---|---|---|
| CONTROL ( | COGNITIVE | CONTROL ( | COGNITIVE | |||
| Working Memory | 0.80 ± 1.06 | 1.04 ± 1.02 | 0.23 ± 0.79 | 0.55 ± 0.69 * | −0.32 (−0.50 – −0.51) | 0.001 (0.003) |
| Selective Attention | 0.23 ± 1.52 | 0.04 ± 1.34 | 0.69 ± 0.60 * | 0.54 ± 0.69 * | 0.15 (−0.02 – 0.31) | 0.076 (0.054) |
| Cognitive Flexibility | −0.21 ± 1.36 | −0.42 ± 1.01 | 0.37 ± 0.70 * | 0.41 ± 0.79 * | −0.03 (−0.15 – 0.22) | 0.693 (0.270) |
| Task Planning | 1.90 ± 0.69 | 1.96 ± 1.11 | 0.70 ± 0.66 * | 0.96 ± 0.83 * | −0.25 (−0.44 – −0.06) | 0.009 (0.003) |
| Decision making | −0.82 ± 1.49 | −0.31 ± 1.39 | 1.13 ± 2.21 | 1.23 ± 2.62 * | −0.09 (−0.70 – 0.52) | 0.776 (0.603) |
Mean ± SD. The data in this table refers to standardised z-scores Between-group differences were estimated as Mean Cognitive—Mean Control value. A 95% confidence interval of between-group differences is shown in parentheses. Significance was analysed by an ANCOVA test. Significance data, controlling for baseline values, age and study level, is shown in parentheses. * represents statistically significant changes after three months regarding baseline values.
Figure 2Three-month change estimates for anthropometric variables by treatment. Mean ± SD. Between-group differences were estimated as Mean Cognitive—Mean Control value. A 95% confidence interval of between-group differences is shown in parentheses. Significance was analysed by an ANCOVA test. Significance data, controlling for baseline anthropometric values and sex, is shown in parentheses. Statistical significant differences that are favourable to the cognitive group have been denoted in bold.
Figure 3Change in biochemical characteristics after three months of intervention. Significance was analysed by an ANCOVA analysis, controlling for baseline biochemical values and sex. The estimated treatment effect is described in parentheses.
Figure 4Proposed explanatory model for the relationship between obesity and executive functioning deficit.